Strand Therapeutics
$153.0M
Funding date
Valuation / Funding
| Date | Round | Amount | Post-Valuation | Growth |
|---|---|---|---|---|
| August 7, 2025 | Later Stage VC (Series B) | $153.0M | N/A | - |
Current Valuation Metrics
Strand Therapeutics is currently valued at $571.0M as of August 7, 2025. The company has raised a total of $255.6M in funding across 1 funding round.
Capital Efficiency
With a capital efficiency ratio of 2.23x, Strand Therapeutics has achieved a valuation that is 2.23 times the total capital raised.
What is Strand Therapeutics Worth in 2026?
Strand Therapeutics is a leading private company in the Drug Discovery sector. Track Strand Therapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.
How Strand Therapeutics Valuation is Determined
Private company valuations like Strand Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.